Skip to main content

Advertisement

Log in

Caution regarding genotyping methodology for a tri-allelic polymorphism in the novel breast cancer susceptibility gene NQO2

  • Letter to the editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Pharoah PD, Antoniou AC, Easton DF, Ponder BA (2008) Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 358:2796–2803. doi:10.1056/NEJMsa0708739

    Article  CAS  PubMed  Google Scholar 

  2. Subramanian A, Salhab M, Mokbel K (2008) Oestrogen producing enzymes and mammary carcinogenesis: a review. Breast Cancer Res Treat 111:191–202. doi:10.1007/s10549-007-9788-0

    Article  CAS  PubMed  Google Scholar 

  3. Gonzalez-Zuloeta Ladd AM, Vasquez AA, Rivadeneira F, Siemes C, Hofman A, Stricker BH, Pols HA, Uitterlinden AG, van Duijn CM (2008) Estrogen receptor alpha polymorphisms and postmenopausal breast cancer risk. Breast Cancer Res Treat 107:415–419. doi:10.1007/s10549-007-9562-3

    Article  CAS  PubMed  Google Scholar 

  4. Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, Selinski S, Mueller T, Ickstadt K, Gilbert M, Ko YD, Baisch C, Pesch B, Harth V, Bolt HM, Vollmert C, Illig T, Eils R, Dippon J, Brauch H (2008) Breast cancer: a candidate gene approach across the estrogen metabolic pathway. Breast Cancer Res Treat 108:137–149. doi:10.1007/s10549-007-9586-8

    Article  CAS  PubMed  Google Scholar 

  5. Talbott KE, Gammon MD, Kibriya MG, Chen Y, Teitelbaum SL, Long CM, Gurvich I, Santella RM, Ahsan H (2008) A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk. Breast Cancer Res Treat 111:481–487. doi:10.1007/s10549-007-9794-2

    Article  CAS  PubMed  Google Scholar 

  6. Yu K-D, Di G-H, Yuan W-T, Fan L, Wu J, Hu Z, Shen Z-Z, Zheng Y, Huang W, Shao Z-M (2009) Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53. Hum Mol Genet. doi:10.1093/hmg/ddp171

  7. Wang W, Le WD, Pan T, Stringer JL, Jaiswal AK (2008) Association of NRH:quinone oxidoreductase 2 gene promoter polymorphism with higher gene expression and increased susceptibility to Parkinson’s disease. J Gerontol A Biol Sci Med Sci 63:127–134

    PubMed  Google Scholar 

  8. Harada S, Fujii C, Hayashi A, Ohkoshi N (2001) An association between idiopathic Parkinson’s disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2. Biochem Biophys Res Commun 288:887–892. doi:10.1006/bbrc.2001.5868

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research is supported by grants from the National Basic Research Program of China (2006CB910501), the Shanghai Science and Technology Committee (06DJ14004, 06DZ19504), Shanghai Municipal Natural Science Foundation (07ZR14025) and the Specialized Research Fund for the Doctoral Program of Higher Education (2008–2010).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhi-Ming Shao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, KD., Di, GH., Fan, L. et al. Caution regarding genotyping methodology for a tri-allelic polymorphism in the novel breast cancer susceptibility gene NQO2. Breast Cancer Res Treat 118, 647–649 (2009). https://doi.org/10.1007/s10549-009-0431-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-009-0431-0

Keywords

Navigation